FORMAPHARMA
ActiveSummary
FORMAPHARMA has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €14k and a net result of €12k. Its solvency ranks better than 88% of 18400 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.3% (low).
Checked score
Score 2025
Axes
Profitability100
Solvency100
Growth-
Track record67
Bankruptcy probability, 12 months
1.3%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days acceptable
Liquidity ample (current ratio 5.69; short-term debt: 16.5% and cash: 63.9% of total assets), and 18.5% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
81.5%
Return on assets
70.2%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
7 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
History
Financials · fiscal year 2025, micro schema
Equity
€14k
Total assets
€18k
Net result
€12k
Working capital
€14k
Turnover and EBIT margin not published: the micro schema does not require them.
Balance-sheet composition
Equity and liabilities €18k
Equity
€14k
Debt
€3k
Debt finances 18.5% of the balance-sheet total.
Key figures and ratios
EBITDA
€16k
Cash flow
€13k
Current ratio
5.69
Debt to equity
0.23
ROE
86.2%
ROA
70.2%
Interest coverage
565.59
Debt ≤ 1 year
€3k
Income taxes
€3k
Annual accounts
| Line | 2025 |
|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €147 |
| Other operating charges640/8 | €50 |
| Gross operating margin9900 | €16k |
| Operating profit (loss)9901 | €16k |
| Financial charges65/66B | €28 |
| Recurring financial charges65 | €28 |
| Profit (loss) for the period before taxes9903 | €16k |
| Income taxes67/77 | €3k |
| Profit (loss) for the period9904 | €12k |
| Profit (loss) for the period to be appropriated9905 | €12k |
| Line | 2025 | |
|---|---|---|
| Assets | ||
| Total assets20/58 | €18k | |
| Formation expenses20 | €1k | |
| Current assets29/58 | €17k | |
| Amounts receivable within one year40/41 | €5k | |
| Trade receivables40 | €5k | |
| Other amounts receivable41 | €608 | |
| Cash at bank and in hand54/58 | €11k | |
| Deferred charges and accrued income490/1 | €72 | |
| Equity and liabilities | ||
| Total equity and liabilities10/49 | €18k | |
| Equity10/15 | €14k | |
| Contributions10/11 | €2k | |
| Profit (loss) carried forward14 | €12k | |
| Amounts payable17/49 | €3k | |
| Amounts payable within one year42/48 | €3k | |
| Trade debts44 | €313 | |
| Suppliers440/4 | €313 | |
| Taxes, remuneration and social security45 | €2k | |
| Taxes450/3 | €2k | |
| Other amounts payable47/48 | €694 | |
| Accrued charges and deferred income492/3 | €357 | |
| Line | 2025 |
|---|---|
| Profit (loss) for the period9904 | €12k |
| + Depreciation and write-downs630 | €147 |
| Operating cash flow (approximation) | €13k |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
More with these figures Sector benchmark What changed Value indication
Timeline · acts, filings and financial milestones
2026
24-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Andenne · 1 establishment unit since 2025
Ground area
746 m²
Parcel 92081A0009/00C005, Wallonia. Linked by address, not a title deed.
1 establishment unit
Rue de la Biche 5, 5300 Andenne
since 20252.373.567.828
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92081A0009/00C005 | Wallonia | 746 m² | - | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteAndenne2.373.567.828
Similar companies · same sector, comparable size
APOTHEEK HET PERRON
BE 0847.829.191
Poperinge · Eq €14,478
CAMILLE HUBY
BE 0800.339.476
Etterbeek · Eq €14,443
Sagenex
BE 0460.691.897
Namur · Eq €14,359
JETPHARMA
BE 0508.755.793
Jette · Eq €14,285
Apotheker Van De Weghe Karen
BE 0662.425.965
Deinze · Eq €14,250
Of 5,221 companies in sector 47730 we hold annual accounts for 3,860. 1,119 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded28-04-2025
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
70200Business and other management consultancy
86995Nutrition and dietetics services
Contact
E-mail
hubert.emma@outlook.be
Phone
+32479374990
Scores and ratios are computed by Checked and are not a credit decision.